Citing the need for animal vaccine research development, DOST said the financial assistance granted to BioAssets Corporation will be used to acquire the latest technologies that will help establish a point-of-need animal health diagnostic system.
“With great potential, Bio Assets Corporation through the BIST program may be able to expand the function of vaccine R&D and address the ASF,” said DOST Secretary Fortunato T. de la Peña. “The BIST program strengthens the capabilities of our local companies and enables them to overcome barriers through the outputs of R&D,” Guevara added.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: